An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.
This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.
This system is provided for Government-authorized use only.
Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.
Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.
By using this system, you understand and consent to the following:
The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.
Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.
Has 200ul Most Proximal Pre-DX Serum Within 5 Years of DX
Matched at a 5-1 Ratio
Matching Factors:
Gender
Age at Randomization (5 year intervals)
Race (W/B/O)
Fiscal Year of Randomization (2 year groups with first group being 3 years)
Year of Blood Draw
Match Ratio: 5 to 1
Match Technique: Individual matching only non-cases as controls.
Additional Matching Comments: Two non-cases desired year of draw were altered to handle match deficiencies.
Analytes:
Anterior Gradient 2
Cancer Antigen 19-9
Carcinoembryonic antigen
DIACETYLSPERMINE
Indole-derivative
Leucine Rich Alpha-2-Glycoprotein 1
Lysophosphatidylcholine(18:0)
Lysophosphatidylcholine(20:3)
N8-ACETYLSPERMIDINE
Regenerating Family Member 3 Alpha
TIMP Metallopeptidase Inhibitor 1
Number of Cases: 175
Number of Controls: 875
The following datasets contain the data available for 2016-0018. The description and documentation for each file is listed below. SAS7bdat and CSV versions of the actual data will be available to CDAS projects approved to use this data.
